NASDAQ: MEDP
Medpace Holdings, Inc.
Healthcare · Medical - Diagnostics & Research
Market Cap
$12.22B
52w High
$628.92
52w Low
$291.28
P/E
26.44
Volume
177.85K
Outstanding Shares
28.56M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 43.34% over the last year. Revenue grew 24.19% over the trailing twelve months. Operating margin moved from 21.16% to 21.02%. Free cash flow grew 36.4% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 31st percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 21.02%. Revenue grew 24.19% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
6
Buy
12
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 20, 2026
Q3 FY26 · EPS est $3.98 · Revenue est $690.68M
View